Clinical Trial Update: A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial update of enzastaurin in Chinese patients with advanced/metastatic solid tumors or lymphoma completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• Enzastaurin (enzastaurin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Solid Tumor, Lymphoma, Malignant | Phase 1 | Status: COMPLETED | Results posted: 2020-09-02